Investment Q&A

Q: Would you buy score now that share consolidated? Also which is the better company score or EGLX?

Q: Hi Peter and team, what do you think the near term and mid term prospects are for GoodFood when consiering the strengthening competition, rising demands (same day delivery etc,) and grocery stores competing more in meal kits?

Thanks you so much.

Q: Do you feel these 2 companies have a good path to long term growth? Is it a good time to initiate a position in either?

Q: I own all for of these companies, totalling about 4% of my portfolio. I'm happy with all of them but I wonder if there is too much overlap between positions and if I'd be better off consolidating. Could you rank in order of both growth potential and risk?

Q: Hello 5i. In your watchlist, what companies are in your top 10?

Q: Hi. Can I have your views on the following scenario: Currently Canopy Growth is sitting at a market cap of 21B. Aphria + Tilray at about 13B. If I am not mistaken, Aphria + Tilray beats Canopy in all the important financial metrics. Does Canopy have a better future growth profile then Aphria + Tilray, or is there a market mismatch here? (APHA up 13.5% today...)

Q: Responding to Wilson on Dec 21 you stated that Acuity Ads was moving up based on a "comparable valuation move" relative to TTD based on "price to sales" and that "momentum in the stock is about the best we have seen".  Valuation relative to competitor MGNI was also mentioned in your response.  Since then AT is up approx 40% while TTD is flat, and MGNI has more than doubled.  Please provide an update on the current relative valuation of AT, TTD and MGNI using the price to sales metric (and any additional metric that you feel may be relevant).  Do you consider AT to still be significantly undervalued relative to TTD and MGNI?  Looking ahead, is it a takeover target?  Do you think that the current momentum on AT will push it higher?  Are there any catalysts on the horizon that may push it higher?  Thanks to 5i I have a substantial position in AT with a cost base of $1.46.  I really like to let my winners run but sitting on a holding with a 19x gain, I need to decide if/when to liquidate some of the position.....thank you.

Q: Hello Peter,
With the US elections and the senate win by the democrats, I was expecting that the US cannabis stocks would surge alot more than the Canadian ones. However, this is not the case and am wondering what that is.. For example. if you look at Aphria and Tilray, and Organirams, they have surged alot more than companies that are actually making money like Curaleaf in the USA .. Do you think this is because US companies are not surging as much due to them being on CDNX (not on TSX or NYSE) and may not be readily available for US investors..Also, can you comment on why Medmen is going through the roof in the last 5 days..? thanks very much

Q: Do you think DocuSign has a lot of potential still, or do you think its shares (like zoom) skyrocketed only from Covid and the company is trading at far too high a premium? Would you enter DOCU today ?

Q: Over the years CSU has been building in my TFSA and UnReg account to the point where it is too large of a single holding. I am thinking of selling enough to buy two stocks and keep an equal amount of CSU. Thoughts are buy KXS and TOI. I would very much appreciate your suggestions/thoughts on this please. Open to US ideas as well. Thanks again.

Q: Assumming you still use a balanced and diversified portfolio in your tfsa. As of today what 20 stocks would you hold. Deduct as many credits as you see fit.

Q: You have stated that AT is cheap compared to its peers.
Could you list some of its peers and highlight the valuation differences.
Many thanks

Q: Any reason what has caused OGI to pop this week, apart from the "Biden" effect?
And what has caused VJET to move up?
Please take two question credits.
Thanks!

Q: Of 6 Wall St. analysts following Palantir 3 have a rare "Sell" on it with 2 Holds average sell PT ~ $17. I know the 5i take on price targets yet last Nov. Peter H. said this stock, then at 17 could be 25 one year out, yet here we are at $36. There's been good news flow on this lately but how much upside could there possibly be and why are these pessimistic analysts down on it?

Q: I own Real Matters (REAL), Topicus.com (TOI.v) and Flex Ltd. (FLEX) within a larger portfolio. I would like to sell two of these 3 companies. Which of the 3 has the best growth potential and would be the best candidate to add the proceeds of the sale to?
Thank you
Frank

Q: With all the Mental Health issues, Depression ect. that are among us these days and Covid making things worse. Are there any drug research companies that are working with Psychedelics that you might see a bright future for? Thanks

Q: PSYK Any thoughts on the potential for this new ETF, longer-term?

Q: Hi, I held both stocks, they are up nicely. I am wondering if it's time to take profit in your opinion?

Thank you,

Q: Hi team, I need to move some shares in-kind from a registered account to my TFSA, in which order would you move the above into the TFSA. Which ones have the greatest growth potential over the next 5 years. I have quite large capital gains in all of these stocks so I am trying to minimize capital gains as I transition these stocks over time into my TFSA
Thanks

Q: Hi Peter,
Greenlane updated the corp presentation on their website & may have dropped a hint into Q4 results.
It notes that $5.7M cash at the end of Q3 and $16.4M cash on Dec 31. I know $4.5M was the exercise of options announced on Dec 2nd. Where did the other $6.2M come from? Operations maybe?? Assuming they didn't rob a bank, how much revenue growth can we expect in Q4 to generate $6.2M cash from operations since they only booked $6.5M revenues in Q3?

Or am I missing something here??

Thanks